Christopher D. Gregory

10.9k total citations · 3 hit papers
108 papers, 8.4k citations indexed

About

Christopher D. Gregory is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Christopher D. Gregory has authored 108 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Immunology, 41 papers in Molecular Biology and 21 papers in Oncology. Recurrent topics in Christopher D. Gregory's work include Phagocytosis and Immune Regulation (38 papers), Immune Cell Function and Interaction (21 papers) and Cell death mechanisms and regulation (17 papers). Christopher D. Gregory is often cited by papers focused on Phagocytosis and Immune Regulation (38 papers), Immune Cell Function and Interaction (21 papers) and Cell death mechanisms and regulation (17 papers). Christopher D. Gregory collaborates with scholars based in United Kingdom, United States and France. Christopher D. Gregory's co-authors include Andrew Devitt, Alan B. Rickinson, John D. Pound, Anne E. Milner, John Gordon, Martin Rowe, Caroline Dive, Odette Moffatt, David L. Simmons and Lawrence S. Young and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Christopher D. Gregory

106 papers receiving 8.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells.

1987 588 citations Christopher D. Gregory et al. profile →
Human CD14 mediates recognition and phagocytosis of apoptotic cells

1998 562 citations Andrew Devitt, Odette Moffatt et al. profile →
The Apoptosis Paradox in Cancer

2022 261 citations Christopher D. Gregory et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher D. Gregory United Kingdom	47	4.1k	3.2k	2.3k	1.1k	892	108	8.4k
Florence M. Hofman United States	56	2.8k 0.7×	2.9k 0.9×	1.4k 0.6×	905 0.8×	705 0.8×	172	9.6k
Peter Schäfer United States	55	2.3k 0.6×	4.7k 1.5×	2.6k 1.2×	1.1k 1.0×	522 0.6×	209	10.9k
T. Matsuyama Japan	46	7.2k 1.8×	3.5k 1.1×	2.8k 1.2×	503 0.5×	691 0.8×	206	12.2k
Anders Waage Norway	49	2.9k 0.7×	3.5k 1.1×	2.4k 1.1×	604 0.6×	447 0.5×	179	9.8k
Bellur S. Prabhakar United States	54	2.9k 0.7×	2.8k 0.9×	1.2k 0.5×	711 0.7×	463 0.5×	205	9.1k
John H. Kersey United States	61	3.4k 0.8×	3.7k 1.2×	2.6k 1.2×	1.3k 1.2×	885 1.0×	207	12.8k
Patrick Concannon United States	60	3.9k 1.0×	7.6k 2.4×	2.7k 1.2×	937 0.9×	709 0.8×	228	15.8k
Mikael Jondal Sweden	55	6.4k 1.6×	3.2k 1.0×	2.8k 1.2×	1.3k 1.2×	633 0.7×	199	12.2k
Takashi Suda Japan	41	5.5k 1.3×	5.7k 1.8×	1.4k 0.6×	461 0.4×	497 0.6×	83	10.2k
Frank R. Jirik Canada	52	2.7k 0.7×	4.1k 1.3×	1.3k 0.6×	573 0.5×	532 0.6×	153	8.0k

Countries citing papers authored by Christopher D. Gregory

Since Specialization

Citations

This map shows the geographic impact of Christopher D. Gregory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher D. Gregory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher D. Gregory more than expected).

Fields of papers citing papers by Christopher D. Gregory

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher D. Gregory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher D. Gregory. The network helps show where Christopher D. Gregory may publish in the future.

Co-authorship network of co-authors of Christopher D. Gregory

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher D. Gregory. A scholar is included among the top collaborators of Christopher D. Gregory based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher D. Gregory. Christopher D. Gregory is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gregory, Christopher D.. (2023). Hijacking homeostasis: Regulation of the tumor microenvironment by apoptosis. Immunological Reviews. 319(1). 100–127. 11 indexed citations

Fu, Han, Kaja Abbas, Stefano Malvolti, et al.. (2023). Impact and cost-effectiveness of measles vaccination through microarray patches in 70 low-income and middle-income countries: mathematical modelling and early-stage economic evaluation. BMJ Global Health. 8(11). e012204–e012204. 11 indexed citations

Rimmer, Michael P., Christopher D. Gregory, & Rod T. Mitchell. (2021). Extracellular vesicles in urological malignancies. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1876(1). 188570–188570. 7 indexed citations

Farnworth, Sarah L., Nicole D. Barth, Margaret Paterson, et al.. (2020). Potential Oncogenic Effect of the MERTK-Dependent Apoptotic-Cell Clearance Pathway in Starry-Sky B-Cell Lymphoma. Frontiers in Immunology. 11. 1759–1759. 9 indexed citations

Vuong, Lynda, Claire Rooney, Brian J. McHugh, et al.. (2019). An Orally Active Galectin-3 Antagonist Inhibits Lung Adenocarcinoma Growth and Augments Response to PD-L1 Blockade. Cancer Research. 79(7). 1480–1492. 104 indexed citations

Oosthuyzen, Wilna, Jessica R. Ivy, Emma Morrison, et al.. (2016). Vasopressin Regulates Extracellular Vesicle Uptake by Kidney Collecting Duct Cells. Journal of the American Society of Nephrology. 27(11). 3345–3355. 49 indexed citations

MacKinnon, Alison C., Nicolaos Avlonitis, Mark Bradley, et al.. (2014). CD133+ Cancer Stem-like Cells in Small Cell Lung Cancer Are Highly Tumorigenic and Chemoresistant but Sensitive to a Novel Neuropeptide Antagonist. Cancer Research. 74(5). 1554–1565. 165 indexed citations

Hume, David, et al.. (2013). Coexpression analysis of large cancer datasets provides insight into the cellular phenotypes of the tumour microenvironment. BMC Genomics. 14(1). 469–469. 32 indexed citations

Gregory, Christopher D.. (2013). Inflammation and cancer revisited: An hypothesis on the oncogenic potential of the apoptotic tumor cell. Autoimmunity. 46(5). 312–316. 4 indexed citations

10.

Wilkinson, Thomas S., Kevin Dhaliwal, Thomas W. Hamilton, et al.. (2009). Trappin-2 Promotes Early Clearance of Pseudomonas aeruginosa through CD14-Dependent Macrophage Activation and Neutrophil Recruitment. American Journal Of Pathology. 174(4). 1338–1346. 29 indexed citations

11.

Spender, Lindsay C., David Simpson, Christopher D. Gregory, et al.. (2009). TGF-β induces apoptosis in human B cells by transcriptional regulation of BIK and BCL-XL. Cell Death and Differentiation. 16(4). 593–602. 72 indexed citations

12.

Pound, John D., Rodger Duffin, Stylianos Bournazos, et al.. (2008). Apoptotic human cells inhibit migration of granulocytes via release of lactoferrin. Journal of Clinical Investigation. 119(1). 20–32. 173 indexed citations

13.

Falize, É., B. Loupias, S. Bouquet, et al.. (2008). Self-similar evolution of astrophysical and laboratory jets: expansion and collimation. Journal of Physics Conference Series. 112(4). 42015–42015. 5 indexed citations

14.

Ogden, Carol Anne, et al.. (2005). Enhanced Apoptotic Cell Clearance Capacity and B Cell Survival Factor Production by IL-10-Activated Macrophages: Implications for Burkitt’s Lymphoma. The Journal of Immunology. 174(5). 3015–3023. 108 indexed citations

15.

Holder, Michelle J., Nicholas M. Barnes, Christopher D. Gregory, & John Gordon. (2005). Lymphoma cells protected from apoptosis by dysregulated bcl-2 continue to bind Annexin V in response to B-cell receptor engagement: A cautionary tale. Leukemia Research. 30(1). 77–80. 8 indexed citations

16.

Gregory, Christopher D. & Andrew Devitt. (2004). The macrophage and the apoptotic cell: an innate immune interaction viewed simplistically?. Immunology. 113(1). 1–14. 221 indexed citations

17.

Moffatt, Odette, et al.. (1999). Macrophage Recognition of ICAM-3 on Apoptotic Leukocytes. The Journal of Immunology. 162(11). 6800–6810. 148 indexed citations

18.

Hammond, Ester M., C. L. Brunet, Gerald D. Johnson, et al.. (1998). Homology between a human apoptosis specific protein and the product of APG5, a gene involved in autophagy in yeast. FEBS Letters. 425(3). 391–395. 70 indexed citations

19.

Holder, Michelle J., S. D. Abbot, Anne E. Milner, et al.. (1993). IL-2 expands and maintains IgM plasmablasts from a CD5⁺ subset contained within the germinal centre cell-enriched (surface IgD⁻/CD39⁻ buoyant) fraction of human tonsil. International Immunology. 5(9). 1059–1066. 19 indexed citations

20.

Milner, Anne E., Gerald D. Johnson, & Christopher D. Gregory. (1992). Prevention of programmed cell death in burkitt lymphoma cell lines by bcl‐2‐dependent and ‐independent mechanisms. International Journal of Cancer. 52(4). 636–644. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact